JAK Inhibitors Have Dupixent In Their Sights For Atopic Dermatitis

 
• By Kevin Grogan
  
Itch
The atopic dermatitis market is set to be a lucrative one • Source: Shutterstock

More from Immunological

More from Therapy Areas